SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001477932-24-001451
Filing Date
2024-03-25
Accepted
2024-03-25 16:15:16
Documents
17
Period of Report
2024-03-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vnrx_8k.htm   iXBRL 8-K 27069
2 PRESS RELEASE vnrx_ex991.htm EX-99.1 20433
8 vnrx_ex991img1.jpg GRAPHIC 2601
  Complete submission text file 0001477932-24-001451.txt   181583

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vnrx-20240325.xsd EX-101.SCH 5720
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vnrx-20240325_lab.xml EX-101.LAB 14667
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vnrx-20240325_cal.xml EX-101.CAL 898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vnrx-20240325_pre.xml EX-101.PRE 9275
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vnrx-20240325_def.xml EX-101.DEF 2099
20 EXTRACTED XBRL INSTANCE DOCUMENT vnrx_8k_htm.xml XML 3904
Mailing Address 1489 WEST WARM SPRINGS ROAD SUITE 110 HENDERSON NV 89014
Business Address 1489 WEST WARM SPRINGS ROAD SUITE 110 HENDERSON NV 89014 1 (646) 650-1351
VOLITIONRX LTD (Filer) CIK: 0000093314 (see all company filings)

IRS No.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36833 | Film No.: 24779374
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)